101 related articles for article (PubMed ID: 10423181)
1. Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice.
Gorman N; Walton HS; Bement WJ; Honsinger CP; Szakacs JG; Sinclair JF; Sinclair PR
Biochem Pharmacol; 1999 Jul; 58(2):375-82. PubMed ID: 10423181
[TBL] [Abstract][Full Text] [Related]
2. Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron.
Gorman N; Ross KL; Walton HS; Bement WJ; Szakacs JG; Gerhard GS; Dalton TP; Nebert DW; Eisenstein RS; Sinclair JF; Sinclair PR
Hepatology; 2002 Apr; 35(4):912-21. PubMed ID: 11915039
[TBL] [Abstract][Full Text] [Related]
3. CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Dalton TP; Sinclair JF; Smith AG; Nebert DW
Toxicol Appl Pharmacol; 2000 Jan; 162(1):60-7. PubMed ID: 10631128
[TBL] [Abstract][Full Text] [Related]
4. Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.
Sinclair PR; Gorman N; Dalton T; Walton HS; Bement WJ; Sinclair JF; Smith AG; Nebert DW
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):149-53. PubMed ID: 9461503
[TBL] [Abstract][Full Text] [Related]
5. Absolute requirement for iron in the development of chemically induced uroporphyria in mice treated with 3-methylcholanthrene and 5-aminolevulinate.
Nakano K; Ishizuka M; Sakamoto KQ; Fujita S
Biometals; 2009 Apr; 22(2):345-51. PubMed ID: 18956144
[TBL] [Abstract][Full Text] [Related]
6. Hexachlorobenzene stimulates uroporphyria in low affinity AHR mice without increasing CYP1A2.
Gorman N; Trask HS; Robinson SW; Sinclair JF; Gerhard GS; Smith AG; Sinclair PR
Toxicol Appl Pharmacol; 2007 Jun; 221(2):235-42. PubMed ID: 17466352
[TBL] [Abstract][Full Text] [Related]
7. Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice.
Constantin D; Francis JE; Akhtar RA; Clothier B; Smith AG
Biochem Pharmacol; 1996 Nov; 52(9):1407-13. PubMed ID: 8937451
[TBL] [Abstract][Full Text] [Related]
8. Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Sinclair JF; Gerhard GS; Szakacs JG; Andrews NC; Levy JE
Hepatology; 2001 Feb; 33(2):406-12. PubMed ID: 11172342
[TBL] [Abstract][Full Text] [Related]
9. Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tarda.
Gorman N; Zaharia A; Trask HS; Szakacs JG; Jacobs NJ; Jacobs JM; Balestra D; Sinclair JF; Sinclair PR
Hepatology; 2007 Jan; 45(1):187-94. PubMed ID: 17187429
[TBL] [Abstract][Full Text] [Related]
10. Relative roles of CYP2E1 and CYP1A2 in mouse uroporphyria caused by acetone.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Szakacs J; Gonzalez FJ; Dalton TP; Nebert DW; Sinclair JF
Arch Biochem Biophys; 2000 Dec; 384(2):383-90. PubMed ID: 11368328
[TBL] [Abstract][Full Text] [Related]
11. Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls-iron interaction: absence in the Cyp1a2(-/-) knockout mouse.
Greaves P; Clothier B; Davies R; Higginson FM; Edwards RE; Dalton TP; Nebert DW; Smith AG
Biochem Biophys Res Commun; 2005 May; 331(1):147-52. PubMed ID: 15845371
[TBL] [Abstract][Full Text] [Related]
12. Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Smith AG; Clothier B; Carthew P; Childs NL; Sinclair PR; Nebert DW; Dalton TP
Toxicol Appl Pharmacol; 2001 Jun; 173(2):89-98. PubMed ID: 11384210
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells.
Bonkovsky HL
Hepatology; 1989 Sep; 10(3):354-64. PubMed ID: 2759551
[TBL] [Abstract][Full Text] [Related]
14. Chlorinated biphenyls induce cytochrome P450IA2 and uroporphyrin accumulation in cultures of mouse hepatocytes.
Sinclair PR; Bement WJ; Lambrecht RW; Gorman N; Sinclair JF
Arch Biochem Biophys; 1990 Sep; 281(2):225-32. PubMed ID: 2118331
[TBL] [Abstract][Full Text] [Related]
15. Experimental hepatic uroporphyria induced by the diphenyl-ether herbicide fomesafen in male DBA/2 mice.
Krijt J; Psenák O; Vokurka M; Chlumská A; Fakan F
Toxicol Appl Pharmacol; 2003 May; 189(1):28-38. PubMed ID: 12758057
[TBL] [Abstract][Full Text] [Related]
16. Uroporphyria in the Cyp1a2-/- mouse.
Phillips JD; Kushner JP; Bergonia HA; Franklin MR
Blood Cells Mol Dis; 2011 Dec; 47(4):249-54. PubMed ID: 21880518
[TBL] [Abstract][Full Text] [Related]
17. Essential role of the AH receptor in the dysfunction of heme metabolism induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Davies R; Clothier B; Robinson SW; Edwards RE; Greaves P; Luo J; Gant TW; Chernova T; Smith AG
Chem Res Toxicol; 2008 Feb; 21(2):330-40. PubMed ID: 18163543
[TBL] [Abstract][Full Text] [Related]
18. Genetic factors influence ethanol-induced uroporphyria in Hfe(-/-) mice.
Gorman N; Trask HW; Bement WJ; Szakacs JG; Elder GH; Balestra D; Jacobs NJ; Jacobs JM; Sinclair JF; Gerhard GS; Sinclair PR
Hepatology; 2004 Oct; 40(4):942-50. PubMed ID: 15382179
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation of iron-induced uroporphyria in mice.
Smith AG; Francis JE
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):29-35. PubMed ID: 8471047
[TBL] [Abstract][Full Text] [Related]
20. Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda.
Nichols RC; Cooper S; Trask HW; Gorman N; Dalton TP; Nebert DW; Sinclair JF; Sinclair PR
Biochem Pharmacol; 2003 Feb; 65(4):545-50. PubMed ID: 12566081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
